Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Exanthema × Triamcinolone Acetonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiodermatitis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Exanthema 1 Dermatitis, Contact 1 Breast Neoplasms 1

Interventions

benralizumab 1 Triamcinolone Acetonide 1 Tetracycline 1 Sirolimus 1 Panitumumab 1 Minocycline 1 Irinotecan 1 IFL protocol 1 Hydrocortisone 1 Gels 1 Fulvestrant 1 Erlotinib Hydrochloride 1 Dapsone 1 Clindamycin 1 Anti-Bacterial Agents 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡